Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
RZLT is expected to report earnings to fall 5.69% to -15 cents per share on September 10
Q2'26
Est.
$-0.15
Q1'26
Beat
by $0.02
Q4'25
Missed
by $0.03
Q3'25
Beat
by $0.04
Q2'25
Missed
by $0.05
The last earnings report on May 12 showed earnings per share of -15 cents, beating the estimate of -18 cents. With 1.01M shares outstanding, the current market capitalization sits at 376.50M.